Annual Accounts Payable:
$48.45M+$33.87M(+232.16%)Summary
- As of today, PCVX annual accounts payable is $48.45 million, with the most recent change of +$33.87 million (+232.16%) on December 31, 2024.
- During the last 3 years, PCVX annual accounts payable has risen by +$41.69 million (+616.96%).
- PCVX annual accounts payable is now at all-time high.
Performance
PCVX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Payable:
$48.96M+$17.55M(+55.86%)Summary
- As of today, PCVX quarterly accounts payable is $48.96 million, with the most recent change of +$17.55 million (+55.86%) on September 30, 2025.
- Over the past year, PCVX quarterly accounts payable has increased by +$30.74 million (+168.74%).
- PCVX quarterly accounts payable is now at all-time high.
Performance
PCVX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PCVX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +232.2% | +168.7% |
| 3Y3 Years | +617.0% | +792.6% |
| 5Y5 Years | +1335.2% | +358.2% |
PCVX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +617.0% | at high | +792.6% |
| 5Y | 5-Year | at high | +1335.2% | at high | +919.8% |
| All-Time | All-Time | at high | +1612.1% | at high | +1815.6% |
PCVX Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $48.96M(+55.9%) |
| Jun 2025 | - | $31.41M(+53.1%) |
| Mar 2025 | - | $20.51M(-57.7%) |
| Dec 2024 | $48.45M(+232.2%) | $48.45M(+165.9%) |
| Sep 2024 | - | $18.22M(+74.1%) |
| Jun 2024 | - | $10.47M(-51.8%) |
| Mar 2024 | - | $21.72M(+48.9%) |
| Dec 2023 | $14.59M(+48.9%) | $14.59M(-7.1%) |
| Sep 2023 | - | $15.70M(-3.5%) |
| Jun 2023 | - | $16.27M(+40.0%) |
| Mar 2023 | - | $11.62M(+18.6%) |
| Dec 2022 | $9.79M | $9.79M(+78.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $5.49M(-22.1%) |
| Jun 2022 | - | $7.04M(+46.6%) |
| Mar 2022 | - | $4.80M(-29.0%) |
| Dec 2021 | $6.76M(-77.3%) | $6.76M(-73.7%) |
| Sep 2021 | - | $25.71M(+8.5%) |
| Jun 2021 | - | $23.70M(-25.6%) |
| Mar 2021 | - | $31.86M(+7.0%) |
| Dec 2020 | $29.79M(+782.3%) | $29.79M(+178.8%) |
| Sep 2020 | - | $10.69M(+318.0%) |
| Jun 2020 | - | $2.56M(-3.5%) |
| Mar 2020 | - | $2.65M(-21.5%) |
| Dec 2019 | $3.38M(+19.3%) | $3.38M |
| Dec 2018 | $2.83M | - |
FAQ
- What is Vaxcyte, Inc. annual accounts payable?
- What is the all-time high annual accounts payable for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. annual accounts payable year-on-year change?
- What is Vaxcyte, Inc. quarterly accounts payable?
- What is the all-time high quarterly accounts payable for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. quarterly accounts payable year-on-year change?
What is Vaxcyte, Inc. annual accounts payable?
The current annual accounts payable of PCVX is $48.45M
What is the all-time high annual accounts payable for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high annual accounts payable is $48.45M
What is Vaxcyte, Inc. annual accounts payable year-on-year change?
Over the past year, PCVX annual accounts payable has changed by +$33.87M (+232.16%)
What is Vaxcyte, Inc. quarterly accounts payable?
The current quarterly accounts payable of PCVX is $48.96M
What is the all-time high quarterly accounts payable for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high quarterly accounts payable is $48.96M
What is Vaxcyte, Inc. quarterly accounts payable year-on-year change?
Over the past year, PCVX quarterly accounts payable has changed by +$30.74M (+168.74%)